PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma
Sign Up to like & getrecommendations! Published in 2024 at "BMC Cancer"
DOI: 10.1186/s12885-024-11846-1
Abstract: Glioblastoma is the most frequent and a particularly malignant primary brain tumor with no efficacy-proven standard therapy for recurrence. It has recently been discovered that excitatory synapses of the AMPA-receptor subtype form between non-malignant brain… read more here.
Keywords: treatment; trial; persurge; perampanel ... See more keywords